Rheumatic Mitral Valve Diseases Treatment Market size is poised to grow at substantial growth rate during the forecast period i.e., between 2025-2037.
The growth of the market can be attributed to the growing prevalence of rheumatic fever, which is the major cause of mitral valve diseases. More than 60% of the cases of rheumatic fever result in mitral valve disease. According to the data by WHO, rheumatic mitral valve disease cause over 288 348 deaths each year. The heart and joints are worst affected by rheumatic fever, with symptoms, such as, blood clotting, calcium accumulation, back flow of blood from atrium to ventricle, and other chronic issues. If detected early, rheumatic mitral valve diseases can be treated using drugs and medication, whereas, surgery is required in critical cases. The increasing R&D activities, to improve drugs, and develop new treatment methods, is estimated to boost the market growth throughout the forecast period.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
|
|
Base Year Market Size (2024) |
|
|
Forecast Year Market Size (2037) |
|
|
Regional Scope |
|
The global rheumatic mitral valve diseases treatment market is segmented by diagnosis into echocardiogram, ECG, Holter monitoring, and others, out of which, the echocardiogram segment is anticipated to hold a notable share in the market during the forecast period on account of the detailed image produced by echocardiogram. This test uses ultrasound waves to generate images of the heart’s structure and function, and can accurately detect any mitral valve diseases. On the basis of treatment, the market is segmented into drugs, valvuloplasty, and surgery. Out of these segments, the drugs sub-segment is further segmented into beta blockers, diuretics, and others. The drugs segment is anticipated to garner the largest revenue over the forecast period, owing to the increasing use of medications to treat mitral valve diseases, as surgeries can be risky and complicated. On the basis of end-user, the rheumatic mitral valve diseases treatment market is segmented into hospitals, diagnostic center, and others, out of which, the hospitals segment is projected to garner the largest share throughout the forecast period, on the back of increasing patient pool, along with complications associated with the treatment, which requires expert attention.
Our in-depth analysis of the global market includes the following segments
|
By Disease Type |
|
|
By Diagnosis |
|
|
By Treatment
|
|
|
By End-User
|
|
North America Market Statistics
North America industry is estimated to hold largest revenue share by 2037, on the back of efficient medical practitioners present in the region, as a result of advanced healthcare system and high government expenditure in healthcare sector.
APAC Market Analysis
The rheumatic mitral valve diseases treatment market in the Asia Pacific region is estimated to witness higher CAGR over the forecast period on the back of improving medical facilities, and advancement in healthcare technologies. Moreover, rheumatic fever is more common in low-income economies, such as, India, Indonesia, and others, which is estimated to boost the market growth in the region.
Author Credits: Radhika Pawar
Copyright © 2025 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?